Document is current

Article History

Received: 27 March 2020

Accepted: 13 August 2020

First Online: 15 September 2020

Compliance with ethical standards

:

: Outside of the submitted work, SHI received speaker honorarium from Mundipharma Research UK in 2017; FC has been an advisory board member and received speaker honorarium fees from Mundipharma International Limited; VD has received speaker honorarium fees and been an advisory board member for Mundipharma International Limited; WH has received research funding from Mundipharma Research UK, and conference attendance fees from Mundipharma Medical Basel, EBSCO Berlin, ISABEL Healthcare and speaker honorarium from AO Foundation Zurich; RL has no competing/conflicts of interests to disclose; TS has received research grants or lecture fees from Bayer, Boehringer Ingelheim, Daiichi-Sankyo and the Gottfried and Julia Bangerter-Rhyner Foundation; IS has no competing/conflicts of interests to disclose.

: All procedures performed in studies included in this guideline involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants involved in the studies included within this guideline.